Leerink Partners assumed coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research note issued to ...

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the ...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief ...

Discover Pediatrix Medical Group's strong Q4 2024 results, strategic restructuring, and optimistic 2025 guidance — projected EBITDA of $215M-$235M.

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

Key achievements included positive Phase 3 ASPEN data for brensocatib in bronchiectasis, record-breaking ARIKAYCE revenues, and advancements in other pipeline programs such as TPIP and ARIKAYCE's ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s ...

Hourglass Capital LLC grew its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 12.6% during the fourth quarter, ...

Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences. Raymond James 46th Annual Institutional Investors ...

Q4 2024 Management View CEO Olivier Loeillot highlighted that Repligen achieved Q4 2024 revenue of $167.5 million and full-year revenue of $634.4 million, meeting the midpoint of their November ...